1,856 reports of this reaction
1.6% of all ACETAMINOPHEN AND CODEINE reports
#5 most reported adverse reaction
FATIGUE is the #5 most commonly reported adverse reaction for ACETAMINOPHEN AND CODEINE, manufactured by Amneal Pharmaceuticals LLC. There are 1,856 FDA adverse event reports linking ACETAMINOPHEN AND CODEINE to FATIGUE. This represents approximately 1.6% of all 113,152 adverse event reports for this drug.
Patients taking ACETAMINOPHEN AND CODEINE who experience fatigue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FATIGUE is a less commonly reported adverse event for ACETAMINOPHEN AND CODEINE, but still significant enough to appear in the safety profile.
In addition to fatigue, the following adverse reactions have been reported for ACETAMINOPHEN AND CODEINE:
The following drugs have also been linked to fatigue in FDA adverse event reports:
FATIGUE has been reported as an adverse event in 1,856 FDA reports for ACETAMINOPHEN AND CODEINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
FATIGUE accounts for approximately 1.6% of all adverse event reports for ACETAMINOPHEN AND CODEINE, making it a notable side effect.
If you experience fatigue while taking ACETAMINOPHEN AND CODEINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.